The FDA has approved a torqueable percutaneous transluminal coronary angioplasty balloon catheter (Glider PTCA Catheter, TriReme Medical, Inc.) for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion. The catheter is available with a balloon length of 4 mm and is designed for focal lesions.

Source: TriReme Medical, Inc.